Wim van Boxtel
0000-0002-2724-1352
5 papers found
Refreshing results…
Prognostic value of PSMA, c-MET and E-cadherin in salivary duct carcinoma
Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients
Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma
Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands.
New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide
Missing publications? Search for publications with a matching author name.